Cargando…
Severe Lenalidomide-Associated Hyperbilirubinemia
Immunomodulatory drugs (IMids), such as thalidomide and lenalidomide, are used to treat plasma cell neoplasms and B-cell malignancies. We present a case of severe direct hyperbilirubinemia in a patient taking lenalidomide-based therapy for plasmacytoma. Imaging was unrevealing, and liver biopsy show...
Autores principales: | Gildea, Daniel T, Roswarski, Joseph L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977541/ https://www.ncbi.nlm.nih.gov/pubmed/36874759 http://dx.doi.org/10.7759/cureus.34408 |
Ejemplares similares
-
A Rare Case of Weil’s Syndrome With Extreme Hyperbilirubinemia in an Urban Setting
por: Ansari, Nida, et al.
Publicado: (2023) -
Hyperbilirubinemia following lenalidomide administration
por: Azmy, Veronica, et al.
Publicado: (2018) -
Leptospirosis: A Rare Cause of Hyperbilirubinemia and Acute Kidney Injury in a Non-endemic Area
por: Kozyk, Marko, et al.
Publicado: (2022) -
Bouveret Syndrome in a Cirrhotic Patient
por: Gildea, Daniel T, et al.
Publicado: (2022) -
Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography
por: Fialho, Andre, et al.
Publicado: (2023)